News & Articles

With this partnership, Repositive is expanding its personalized medicine capabilities to support more biopharma customers

The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring

Catch up on part one of our exclusive webinar series to hear Dr. Frank Peacock dispel the four lies of high-sensitivity troponin

Increasing Portuguese market presence by enhancing sales and after-sales support networks

Join us on Friday, February 26, to find out how to effectively profile the host response to COVID-19 infection using the next-generation automated ELISA, Ella

Find out how to overcome the challenges involved with establishing reference intervals for clinical interpretation in this on-demand webinar

New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific

The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs

Take a look back at the technologies, innovations and clinical advances that hit the headlines over the past 12 months

Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape

Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing

Which new products made the most difference to your lab work this year?

The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance

Watch this webinar on demand to learn about the host immune response to COVID-19

Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication

Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies